NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
| Autor: | Hoppe RT, Advani RH, Ai WZ, Ambinder RF, Aoun P, Armand P, Bello CM, Benitez CM, Bierman PJ, Chen R, Dabaja B, Dean R, Forero A, Gordon LI, Hernandez-Ilizaliturri FJ, Hochberg EP, Huang J, Johnston PB, Kaminski MS, Kenkre VP, Khan N, Maddocks K, Maloney DG, Metzger M, Moore JO, Morgan D, Moskowitz CH, Mulroney C, Rabinovitch R, Seropian S, Tao R, Winter JN, Yahalom J, Burns JL, Ogba N |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2018 Mar; Vol. 16 (3), pp. 245-254. |
| DOI: | 10.6004/jnccn.2018.0013 |
| Abstrakt: | The NCCN Clinical Practice Guidelines in Oncology for Hodgkin Lymphoma (HL) provide recommendations for the management of adult patients with HL. The NCCN Guidelines Panel meets at least annually to review comments from reviewers within the NCCN Member Institutions, examine relevant data, and reevaluate and update the recommendations. These NCCN Guidelines Insights summarize recent updates centered on treatment considerations for relapsed/refractory classic HL. (Copyright © 2018 by the National Comprehensive Cancer Network.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|